MediSapiens to Use $1M Investment to Make Research Software Work for Personalized Medicine

The company is targeting its software at oncologists who would use it to develop personalized cancer treatments for individual patients.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.